Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer.

MLA

Ruixin, Sun, et al. “Expressing IL-15/IL-18 and CXCR2 Improve Infiltration and Survival of EGFRvIII-Targeting CAR-T Cells in Breast Cancer.” Biochemical Pharmacology, vol. 212, June 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bcp.2023.115536.

APA

Ruixin, S., Yifan, L., Chuanlong, W., Min, Z., Hong, L., Guoxiu, D., Zhengyang, L., Yansha, S., Yiwei, D., Jingwen, S., Mingliang, F., Bizhi, S., Hua, J., & Zonghai, L. (2023). Expressing IL-15/IL-18 and CXCR2 improve infiltration and survival of EGFRvIII-targeting CAR-T cells in breast cancer. Biochemical Pharmacology, 212, N.PAG. https://doi.org/10.1016/j.bcp.2023.115536

Chicago

Ruixin, Sun, Liu Yifan, Wu Chuanlong, Zhou Min, Luo Hong, Du Guoxiu, Liu Zhengyang, et al. 2023. “Expressing IL-15/IL-18 and CXCR2 Improve Infiltration and Survival of EGFRvIII-Targeting CAR-T Cells in Breast Cancer.” Biochemical Pharmacology 212 (June): N.PAG. doi:10.1016/j.bcp.2023.115536.